8/31/2022Mayo Clinic, Hibiscus and Innoforce Announce Mayflower Cell and Gene T...

8/31/2022Financial-related Company News Digest (August 2022)

8/31/2022IQVIA: Chinese Hospital Drug Market Down 5.8% in Q2/2022

8/31/2022Snapshot of Top Ten Drug Products by Representative Hospital Sales in ...

8/30/2022USCBC 2022 Member Survey: China's COVID-19 Policies Are the Top Chall...

8/30/2022RoosterBio and MBL Beijing Biotech Partner to Accelerate Advanced Ther...

8/29/2022Porton Advanced, Royaltech Accelerate Development of mRNA Drugs in Chi...

8/26/2022NMPA Announces OTC Switch of Omeprazole Enteric-Coated Tablets

8/26/2022Recent Official and Executive Moves

8/24/2022NMPA Suspends Import, Sales and Use of UCB's Epilepsy Drug Keppra

8/22/2022Drug R&D and Approvals in China – July Update on YouTube (PharmCube)

8/22/2022New Rational Drug Use Rules in China Benefit Pediatric, Anti-Tumor And...

8/19/2022Lundbeck Fails China Trial for CGRP Migraine Drug Vyepti, Undermining ...

8/18/2022Roche to Pay $60M Upfront in License Deal for Jemincare's Potential Pr...

8/18/2022Kidney Disease Drugs A Hot Spot for July In-licensing (PharmaDJ)

8/18/2022Vision 2028: How China Could Impact the Global Biopharma Industry (McK...

8/17/2022AbbVie to Discontinue Phase 1 Trial for I-Mab's Anti-CD47 Therapy for ...

8/17/2022Review of Chinese Retail Drug Sales in Q1/2022

8/17/2022Huadong Completes Acquisition of 35% Stake in Heidelberg Pharma

8/17/2022Menarini and SciClone Enter License Pact for Vaborem in China for An...

8/17/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M10:...

8/17/2022WuXi STA Breaks Ground for 2nd Drug Manufacturing Facility in the U.S.

8/15/2022Chinese Pharma Cos Reportedly Slashing Headcount as Performance Dims

8/12/2022Zai Lab Throws the Towel in CD47 Race and Decides to 'Deprioritize' I...

8/12/2022Janssen Licences TESSA Technology from WuXi ATU

8/12/2022Recent Official and Executive Moves

8/11/2022Snapshot of BMI System Financial Performance in H1/2022

8/11/2022IQVIA: Overall Chinese Pharma Market Up 8.3% in 2021

8/10/2022Chiesi Group Continues China Business Expansion: China Daily

8/9/2022BioDuro-Sundia and X-Chem Enter Partnership to Launch DEL Services in ...

Page:66/361 Total number of articles:10805: [First][<<] [64] [65] [66] [67] [68] [>>] [End]